A detailed history of Black Rock Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Black Rock Inc. holds 12,132,397 shares of NVCR stock, worth $374 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,132,397
Previous 9,084,412 33.55%
Holding current value
$374 Million
Previous $142 Million 46.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.83 - $24.05 $36.1 Million - $73.3 Million
3,047,985 Added 33.55%
12,132,397 $208 Million
Q1 2024

May 10, 2024

BUY
$12.42 - $17.29 $3.63 Million - $5.06 Million
292,377 Added 3.33%
9,084,412 $142 Million
Q4 2023

Feb 13, 2024

BUY
$11.13 - $15.78 $10.3 Million - $14.7 Million
929,654 Added 11.82%
8,792,035 $131 Million
Q3 2023

Nov 13, 2023

SELL
$16.15 - $42.35 $4.18 Million - $11 Million
-258,636 Reduced 3.18%
7,862,381 $127 Million
Q2 2023

Aug 11, 2023

SELL
$40.29 - $82.51 $8.22 Million - $16.8 Million
-203,904 Reduced 2.45%
8,121,017 $337 Million
Q1 2023

May 12, 2023

BUY
$56.44 - $118.81 $40.6 Million - $85.5 Million
719,265 Added 9.46%
8,324,921 $501 Million
Q4 2022

Feb 13, 2023

BUY
$63.98 - $85.37 $14.4 Million - $19.3 Million
225,711 Added 3.06%
7,605,656 $558 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $3.18 Million - $4.19 Million
46,794 Added 0.64%
7,379,945 $561 Million
Q2 2022

Aug 12, 2022

BUY
$56.6 - $89.9 $34 Million - $54 Million
600,638 Added 8.92%
7,333,151 $510 Million
Q1 2022

May 12, 2022

BUY
$60.15 - $84.52 $2.6 Million - $3.65 Million
43,157 Added 0.65%
6,732,513 $558 Million
Q4 2021

Feb 10, 2022

SELL
$75.08 - $121.99 $2.58 Million - $4.19 Million
-34,324 Reduced 0.51%
6,689,356 $502 Million
Q3 2021

Nov 09, 2021

BUY
$116.17 - $194.55 $23.7 Million - $39.7 Million
203,900 Added 3.13%
6,723,680 $781 Million
Q2 2021

Aug 11, 2021

BUY
$130.4 - $225.58 $850 Million - $1.47 Billion
6,519,780 New
6,519,780 $1.45 Billion

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.